JPMorgan Healthcare Lead ETFJDOCETF
13F holders, Q3 2024 (September 30)3holders
1new positions
1sold out
$60.79avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding JPMorgan Healthcare Lead ETF (JDOC) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were JPMorgan Chase & Co. ($5.4M), Ignite Planners, LLC ($204K) and UBS Group AG ($1K).
- Company
- JPMorgan Healthcare Lead ETF
- CUSIP
- 46654Q765
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 1 | $352K |
All 13F filers, Q2 2024 → Q3 2024: 17 shares bought and 6,593 shares sold, net −6,576 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| JPMorgan Chase & Co. | 0.00% | No change | 88,196 | $5.4M |
| Ignite Planners, LLC | 0.05% | Reduce -14.9% | 3,354 | $204K |
| UBS Group AG | 0.00% | New | 17 | $1K |
"% of holder's portfolio" is JDOC's weight in each manager's 13F, not the share of JPMorgan Healthcare Lead ETF the manager owns.